L. Maurette et al. / Tetrahedron 60 (2004) 10077–10098
10091
(C–H), 2822 (OC–H), 1604, 1490 (aromatic C–C), 1451 (C–
H), 1224, 1178, 1069 (C–O). The main characteristics of
three side-products (8a–10a, 10–25%) are listed below.
solution of [5]pericyclyndiol 7a (80 mg, 0.12 mmol) in THF
(3 mL) at K78 8C. After stirring for 15 min, methyl iodide
was added (115 mL, 1.85 mmol), and the temperature was
allowed to warm up to K25 8C. DMSO (20 mL; 0.23 mmol)
was added and stirring was continued at K25 8C for 1 h,
then at r.t. for a further 1 h. The reaction mixture was
quenched with saturated aqueous NH4Cl solution, and
extracted with diethylether. The organic layer was washed
with aqueous NH4Cl and brine, dried with magnesium
sulfate and the solvent was removed under reduced pressure.
Purification by column chromatography (heptane/acetone
7:3) gave 11a as a yellow oil (80 mg, 92%). Rfz0.26
(heptane/acetone 7:3). MS (DCI/NH3): m/zZ738 ([MC
NH4]C), 689 ([MKCH3O]C). MS (APCI/CH3CN): m/zZ
730 ([MKCH3OCCH3CN]C). 1H NMR: dZ3.37–3.69 (8s,
15H; OCH3), 7.33–7.45 (m, 15H; m-, p-CH), 7.74–7.90 (m,
10H; o-CH). 13C{1H} NMR: dZ53.73 (OCH3), 72.35
(OC(OMe)Ph), 83.42–83.86 (C^C), 126.57 (m-, p-CH),
128.32–129.16 (o-CH), 139.53 (ipso-C–C–OMe). IR: nZ
3067–2902 (C–H), 2827 (OC–H), 1601, 1490, 1451
(aromatic C–C), 1230, 1178, 1154, 1071 (C–O). Notice:
the cylization step (4.8) and methylation steps can also be
performed subsequently in one pot.
4.1.8. 4-Hydroxy-7,10,17-trimethoxy-1,4,7,10,13-penta-
phenylpentadeca-2,5,8,11,14-pentayn-1-one
(8a).
Rfz0.26 (heptane/acetone 8:2). MS (DCI/NH3): m/zZ710
1
([MCNH4]C). H NMR: dZ2.76 (s, 1H; ^C–H), 3.50–
3.55 (m, 9H; OCH3), 7.32–7.46 (m, 12H; Csp3-phenyl m-,
p-CH), 7.52–7.58 (m, 3H; benzoyl m-, p-CH), 7.72–7.82 (m,
8H; Csp3-phenyl o-CH), 8.05–8.10 (m, 2H; benzoyl o-CH).
13C{1H} NMR: dZ53.62 (OCH3), 65.56 (OC(OH)Ph),
71.97 (OC(OMe)Ph), 75.52 (^C–H), 80.64 (C^CH),
81.21–91.87 (C^C), 125.78–136.33 (aromatic CH), 139.36
(ipso-C–C–OCH3), 139.89 (ipso-C–C–OH), 177.37 (CZ
O). IR: nZ3571 (O–H), 3305 (^C–H), 1649 (C]O).
4.1.9. 3,6,9,18,21,24-Hexamethoxy-3,6,9,12,15,18,21,24-
octaphenylhexacosa-1,4,7,10,13,16,19,22,25, 28-nonayn-
12,15-diol (9a). Rfz0.15 (heptane/acetone 8:3). MS (DCI/
NH3): m/zZ1168 ([MCNH4]C). 1H NMR: dZ2.75 (s, 2H;
^C–H), 3.09 (m, 2H; OH) 3.46–3.51 (m, 18H; OCH3),
7.31–7.34 (m, 18H; m-, p-CH), 7.71–7.73 (m, 12H; o-CH).
13C{1H} NMR: dZ53.33 and 53.48 (OCH3), 65.17
(OC(OH)Ph), 71.92 (OC(OMe)Ph), 75.45 (^C–H), 80.52
(C^CH), 82.55–86.34 (C^C), 125.84–129.01 (aromatic
CH), 139.44 (ipso-C–C–OMe), 140.76 (ipso-C–C–OH). IR:
nZ3571 (O–H), 3305 (^C–H).
4.1.13. Dicobalthexacarbonyl-1,4,13-trimethoxy-1,4,7,
10,13-pentaphenylcyclopentadeca-2,5,8, 11,14-pentayn-
7,10-diol (12a), and side-product. Dicobaltoctacarbonyle
(126 mg, 0.37 mmol) was added into a solution of
[5]pericyclyndiol 7a (256 mg, 0.37 mmol) in diethylether
(25 mL) at 0 8C. The color turned red, and the reaction was
monitored by TLC. After stirring for 30 min, the solution
was concentrated and the oily residue was chromatographed
over silicagel (heptane/acetone 8:2). The dinuclear complex
12a was obtained as a red-orange oil (231 mg, 64%).
Rfz0.33 (heptane/acetone 7:3). MS (APCIO0/CH3CN):
m/zZ716 ([MKCo2(CO)6–OHCCH3CN]C), 702 ([MK
Co2(CO)6–CH3OCCH3CN]C). MS (MALDI/dithranol–
NaI): m/zZ1001 ([MCNa]C), 715 ([MCNa–
Co2(CO)6]C). Elemental analysis % (calcd): CZ65.96
(66.27), HZ4.22 (3.71), CoZ10.07 (12.04). 1H NMR:
dZ3.27–3.72 (m, 9H; OCH3), 7.19–7.42 (m, 15H; m-,
p-CH), 7.52–7.80 (m, 10H; o-CH). 13C{1H} NMR: dZ
52.11–52.92 (OCH3), 72.02 (OC(OMe)Ph), 85.26–86.03
(C^C), 100.72–101.55 ((C^C)(Co2(CO)6)), 125.56–
129.16 (aromatic CH), 139.54 (ipso-C–C–OMe), 141.78
(ipso-C–C–OH), 198.75 (Co2(C^O)6). IR: nZ3689, 3536
(O–H), 2097, 2063 and 2037 (CoC^O).
4.1.10. 4,16-Dihydroxy-7,10,13-trimethoxy-1,4,7,10,13,
16,19-heptaphenylnonadeca-2,5,8,11,14,17-hexayn-1,19-
dione (10a). Rfz0.15 (heptane/acetone 8:2). MS (DCI/
NH3): m/zZ944 ([MCNH4]C). 1H NMR: dZ3.49–3.52
(m, 9H; OCH3), 3.90 (m, 2H; OH), 7.25–7.44 (m, 15H;
Csp3-phenyl m-, p-CH), 7.54–7.60 (m, 6H; benzoyl m-,
p-CH), 7.70–7.80 (m, 10H; Csp3–phenyl o-C6H5), 8.04–
8.10 (m, 4H; benzoyl o-CH). 13C{1H} NMR: dZ53.62
(OCH3), 64.94 (OC(OH)Ph), 72.02 (OC(OMe)Ph), 81.64–
85.79 and 92.02 (C^C), 125.89–136.33 (aromatic CH),
139.12 (ipso-C–C–OMe), 139.78 (ipso-C–C–OH), 177.52
(C]O).
4.1.11. 1,4,13-Trimethoxy-1,4,13-tris(4-methoxyphenyl)-
7,10-diphenyl-cyclopentadeca-2,5,8,11, 14-pentayn-7,10-
diol (7b). The above Section 4.1.9 for the preparation of 7a
was applied to tetrayne 2b (412 mg, 0.75 mmol) and
dibenzoylacetylene 1 (176 mg, 0.75 mmol) to afford
trianisyl-[5]pericyclyne 7b as an orange oil (180 mg,
31%). Rfz0.20 (heptane/EtOAc 7:3). MS (DCI/NH3):
m/zZ800 ([MCNH4]C), 768 ([MKMeOHCNH4]C), 751
The less polar tetranuclear complex 12a0 was also isolated
as a red oil from the chromatography column (79 mg, 17%):
bis(dicobalthexacarbonyl)-1,4,13-trimethoxy-1,4,7,10,13-
penta-phenylcyclo-pentadeca-2,5,8,11,14-pentayn-7,10-
diol (12a0) Rfz0.48 (heptane/acetone 7:3). MS (MALDI/
dithranol–NaI): m/zZ715 ([MCNa–2Co2(CO)6]C).
Elemental analysis % (calcd): CZ57.79 (56.98), HZ3.00
1
([MKMeO]C). H NMR: dZ3.30–3.62 (m, 9H; OCH3),
3.69–3.86 (m, 9H; C6H4OCH3), 6.78–6.92 (m, 6H; p-anisyl
m-CH), 7.30–7.40 (m, 6H; phenyl m-, p-CH), 7.51–7.84 (m,
10H; o-CH). 13C{1H} NMR: dZ53.44 (Csp3–OCH3), 55.45
(C6H4OCH3), 65.22 (OC(OH)Ph), 71.76 (OC(OMe)An),
81.63–85.85 (C^C), 113.87 (p-anisyl m-CH), 125.94–
129.07 (phenyl CH), 128.63 (p-anisyl o-CH), 131.45 (anisyl
ipso-C–C–OMe), 140.67 (phenyl ipso-C–C–OH), 160.15
(p-anisyl p-C–OMe).
1
(2.87). H NMR: dZ3.29–3.57 (m, 9H; OCH3), 7.21–7.44
(m, 15H; m-, p-CH), 7.59–7.80 (m, 10H; o-CH). IR: nZ
3689, 3409 (O–H), 2095, 2064, 2035 (Co2(C^O)6).
4.1.14. Dicobalthexacarbonyl-1,4,13-trimethoxy-1,4,13-
tris(4-methoxyphenyl)-7,10-diphenyl-cyclopentadeca-
2,5,8,11,14-pentayn-7,10-diol (12b). The above Section
4.1.13 for the preparation of 12a was applied to
4.1.12. 1,4,7,10,13-Pentamethoxy-1,4,7,10,13-penta-
phenylcyclopentadeca-2,5,8,11,14-pentayne (11a).
n-Butyllithium (105 mL, 0.23 mmol) was syringed into a